125 related articles for article (PubMed ID: 3687598)
1. Effects of a 5-lipoxygenase inhibitor (L-651,392) on primary and late pulmonary responses to ascaris antigen in the squirrel monkey.
McFarlane CS; Hamel R; Ford-Hutchinson AW
Agents Actions; 1987 Oct; 22(1-2):63-8. PubMed ID: 3687598
[TBL] [Abstract][Full Text] [Related]
2. Late pulmonary responses induced by Ascaris allergen in conscious squirrel monkeys.
Hamel R; McFarlane CS; Ford-Hutchinson AW
J Appl Physiol (1985); 1986 Dec; 61(6):2081-7. PubMed ID: 3804916
[TBL] [Abstract][Full Text] [Related]
3. Activity of a novel hydroquinone inhibitor of leukotriene synthesis (U-66,858) in the rhesus monkey Ascaris reactor.
Johnson HG; Stout BK
Int Arch Allergy Appl Immunol; 1988; 87(2):204-7. PubMed ID: 3192307
[TBL] [Abstract][Full Text] [Related]
4. Effects of a contractile prostaglandin antagonist (L-640,035) upon allergen-induced bronchoconstriction in hyperreactive rats and conscious squirrel monkeys.
McFarlane CS; Piechuta H; Hall RA; Ford-Hutchinson AW
Prostaglandins; 1984 Aug; 28(2):173-82. PubMed ID: 6505224
[TBL] [Abstract][Full Text] [Related]
5. Pharmacology of MK-0591 (3-[1-(4-chlorobenzyl)-3-(t-butylthio)-5-(quinolin-2-yl-methoxy)- indol-2-yl]-2,2-dimethyl propanoic acid), a potent, orally active leukotriene biosynthesis inhibitor.
Brideau C; Chan C; Charleson S; Denis D; Evans JF; Ford-Hutchinson AW; Fortin R; Gillard JW; Guay J; Guévremont D
Can J Physiol Pharmacol; 1992 Jun; 70(6):799-807. PubMed ID: 1330258
[TBL] [Abstract][Full Text] [Related]
6. Role of cyclooxygenase products of arachidonic acid metabolism in Ascaris antigen-induced bronchoconstriction in sensitized dogs.
Richards IM; Griffin RL; Oostveen JA; Elfring G; Conder GA
J Pharmacol Exp Ther; 1988 May; 245(2):735-41. PubMed ID: 3130478
[TBL] [Abstract][Full Text] [Related]
7. L-656,224 (7-chloro-2-[(4-methoxyphenyl)methyl]-3- methyl-5-propyl-4-benzofuranol): a novel, selective, orally active 5-lipoxygenase inhibitor.
Belanger P; Maycock A; Guindon Y; Bach T; Dollob AL; Dufresne C; Ford-Hutchinson AW; Gale PH; Hopple S; Lau CK
Can J Physiol Pharmacol; 1987 Dec; 65(12):2441-8. PubMed ID: 2835137
[TBL] [Abstract][Full Text] [Related]
8. The effects of nifedipine and verapamil on antigen-induced bronchoconstriction in dogs.
Malo PE; Wasserman MA; Griffin RL
Eur J Pharmacol; 1983 Aug; 92(1-2):69-75. PubMed ID: 6194999
[TBL] [Abstract][Full Text] [Related]
9. Ascaris-induced bronchoconstriction in primates experimentally infected with Ascaris suum ova.
Richards IM; Eady RP; Jackson DM; Orr TS; Pritchard DI; Vendy K; Wells E
Clin Exp Immunol; 1983 Nov; 54(2):461-8. PubMed ID: 6652969
[TBL] [Abstract][Full Text] [Related]
10. Effects of FPL 55712, ETYA and aminophylline upon Ascaris-induced bronchoconstriction in cynomolgus monkeys.
Mielens ZE; Gorman WG
Int Arch Allergy Appl Immunol; 1984; 75(4):368-74. PubMed ID: 6500722
[TBL] [Abstract][Full Text] [Related]
11. Substituted (pyridylmethoxy)naphthalenes as potent and orally active 5-lipoxygenase inhibitors; synthesis, biological profile, and pharmacokinetics of L-739,010.
Hamel P; Riendeau D; Brideau C; Chan CC; Desmarais S; Delorme D; Dubé D; Ducharme Y; Ethier D; Grimm E; Falgueyret JP; Guay J; Jones TR; Kwong E; McAuliffe M; McFarlane CS; Piechuta H; Roumi M; Tagari P; Young RN; Girard Y
J Med Chem; 1997 Aug; 40(18):2866-75. PubMed ID: 9288168
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of IgE-mediated leukotriene generation and bronchoconstriction in primates with a new 5-lipoxygenase inhibitor, E6080.
Katayama S; Sakuma Y; Abe S; Tsunoda H; Yamatsu I; Katayama K
Int Arch Allergy Immunol; 1993; 100(2):178-84. PubMed ID: 8443470
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of allergen-induced bronchoconstriction in hyperreactive rats as a model for testing 5-lipoxygenase inhibitors and leukotriene D4 receptor antagonists.
Piechuta H; Ford-Hutchinson AW; Letts LG
Agents Actions; 1987 Oct; 22(1-2):69-74. PubMed ID: 2825489
[TBL] [Abstract][Full Text] [Related]
14. Sulfidopeptide leukotrienes mediate acrolein-induced bronchial hyperresponsiveness.
Leikauf GD; Doupnik CA; Leming LM; Wey HE
J Appl Physiol (1985); 1989 Apr; 66(4):1838-45. PubMed ID: 2543658
[TBL] [Abstract][Full Text] [Related]
15. Chronological relationships between mediator release and changes in airway dynamics during an ascaris response in sensitive cynomolgus monkeys.
Malo PE
Prostaglandins Leukot Essent Fatty Acids; 1989 Feb; 35(2):105-11. PubMed ID: 2470112
[TBL] [Abstract][Full Text] [Related]
16. Effects of a selective phosphodiesterase IV inhibitor (CDP-840) in a leukotriene-dependent non-human primate model of allergic asthma.
Jones TR; McAuliffe M; McFarlane CS; Piechuta H; Macdonald D; Rodger IW
Can J Physiol Pharmacol; 1998 Feb; 76(2):210-7. PubMed ID: 9635162
[TBL] [Abstract][Full Text] [Related]
17. L-651,392: a novel, potent and selective 5-lipoxygenase inhibitor.
Guindon Y; Girard Y; Maycock A; Ford-Hutchinson AW; Atkinson JG; Bélanger PC; Dallob A; DeSousa D; Dougherty H; Egan R
Adv Prostaglandin Thromboxane Leukot Res; 1987; 17A():554-7. PubMed ID: 2821766
[No Abstract] [Full Text] [Related]
18. Capsaicin and histamine antagonist-sensitive mechanisms in the immediate allergic reaction of pig airways.
Alving K; Matran R; Lacroix JS; Lundberg JM
Acta Physiol Scand; 1990 Jan; 138(1):49-60. PubMed ID: 2309568
[TBL] [Abstract][Full Text] [Related]
19. 5-Lipoxygenase inhibitors and allergic conjunctivitis reactions in the guinea-pig.
Garceau D; Ford-Hutchinson AW; Charleson S
Eur J Pharmacol; 1987 Nov; 143(1):1-7. PubMed ID: 2826183
[TBL] [Abstract][Full Text] [Related]
20. Effects of a 5-lipoxygenase inhibitor (L-651,392) and leukotriene D4 antagonist (L-649,923) in two animal models of immediate hypersensitivity reactions.
Letts LG; McFarlane C; Piechuta H; Ford-Hutchinson AW
Adv Prostaglandin Thromboxane Leukot Res; 1987; 17B():1007-11. PubMed ID: 2960143
[No Abstract] [Full Text] [Related]
[Next] [New Search]
